In:
International Journal of Cancer, Wiley, Vol. 136, No. 12 ( 2015-06-15), p. 2932-2939
Kurzfassung:
What's new? Vitamin B6 status is reflected in the measure of its active form, pyridoxal 5'‐phosphate (PLP). Studies disagree, however, as to whether or not PLP measures are meaningful in relation to cancer risk, which has necessitated a search for additional markers of vitamin B6 status. In this study, inflammation‐related changes in vitamin B6 catabolism were captured effectively by a novel marker, the 4‐pyridoxic acid (PA) /(pyridoxal (PL) + PLP) ratio (PAr). Analyses based on the detection of PAr suggest that increased vitamin B6 metabolism and disposal are linked to increased cancer risk, particularly for lung cancer.
Materialart:
Online-Ressource
ISSN:
0020-7136
,
1097-0215
Sprache:
Englisch
Verlag:
Wiley
Publikationsdatum:
2015
ZDB Id:
218257-9
ZDB Id:
1474822-8